ELEGANCE
Recruiting
2,766 enrolled
Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases
Completed
3,883 enrolled
IMPULSE
Recruiting
240 enrolled
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
Active not recruiting
1 enrolled
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
Completed
779 enrolled 9 charts
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole
Completed
16,989 enrolled
A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer
Not yet recruiting
200 enrolled
Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients
Completed
50 enrolled 15 charts
NASBP-B-09
Not yet recruiting
100 enrolled
NEMO
Unknown
300 enrolled
TIBCaP
Completed
1,268 enrolled
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
Unknown
1,000 enrolled
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
Unknown
1,354 enrolled
NUTRIBREAST
Unknown
300 enrolled
Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy
Completed
760 enrolled
Breast Cancer Treatment Based on Organ-like Culture
Unknown
300 enrolled
Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors
Completed
115 enrolled 6 charts
LOGRIBMET
Completed
115 enrolled 14 charts
Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole
Completed
58 enrolled
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer
Completed
200 enrolled
PACT
Terminated
4,923 enrolled
Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy
Completed
72 enrolled
Ax-003
Completed
1,600 enrolled